A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

BACKGROUND: The enhanced thrombotic milieu in diabetes contributes to increased risk of vascular events. Aspirin, a key antiplatelet agent, has inconsistent effects on outcomes in diabetes and the best dosing regimen remains unclear. This work investigated effects of aspirin dose and interaction wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, William A. E., Sagar, Rebecca, Kurdee, Zeyad, Hawkins, Fladia, Naseem, Khalid M., Grant, Peter J., Storey, Robert F., Ajjan, Ramzi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684134/
https://www.ncbi.nlm.nih.gov/pubmed/34920734
http://dx.doi.org/10.1186/s12933-021-01427-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684134/
https://www.ncbi.nlm.nih.gov/pubmed/34920734
http://dx.doi.org/10.1186/s12933-021-01427-y

Ejemplares similares